Acumen Pharmaceuticals Inc (ABOS) Stock Price, Quote & News

Company Profile

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate Sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2, which has completed the INTERCEPT-AD phase 1 clinical trial and in ALTITUDE-AD phase 2 clinical trial to target soluble amyloid-beta oligomers. It has a collaboration and license agreement with Halozyme, Inc. for t...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 344 4190

Website: acumenpharm.com

Address:

1210-1220 Washington St., Suite 210, Newton, United States

RoBERTTR87 Feb. 25 at 3:29 PM

$IBRX $SLS $ABOS $CABA $AKBA Best decision I joined your groups! I am learning a lot!

2 · Reply

jacksparo Feb. 25 at 1:09 PM

$IBRX $SLS $ABOS $CABA $AKBA I will be taking all the possible and needed notes about my incoming or current trades in some important micro/small cap biotech in the market! And I will share all my updates in Special Biotech Telegram live group ✅✅📈✅✅📈!

1 · Reply

Drerekcohert90 Feb. 24 at 10:15 PM

$SLS $IBRX $ABOS $CABA $ALT Jack I will spam the board for you lol! I am serious you did very well in IBRX but we need a bigger win in SLS!

12 · Reply

jacksparo Feb. 24 at 7:15 PM

$SLS $IBRX $ABOS $CABA $ALT Strong day across some Biotech spots!

0 · Reply

jacksparo Feb. 24 at 3:27 AM

$SLS $IBRX $OCGN $ALT $ABOS The week just started today . More action expected ✅✅! I am sharing all my updates and live charts 📊 info in my Biotech Specail telegram group and it is growing every day 📈📈! I am not in rush and I have plans for both short term and long term. Stay focused and avoid the unnecessary hassle ✅!

1 · Reply

Geraldgenofranco1953 Feb. 23 at 2:26 PM

$SLS $ALT $ABOS $GUTS Let us go Jack!

0 · Reply

jacksparo Feb. 23 at 1:26 PM

$SLS $ALT $ABOS $GUTS I will be watching and sharing my live updates in my Telegram Biotech group let us see what this week will bring!

1 · Reply

topstockalerts Feb. 20 at 9:30 PM

After Hours Top Gainers $VHUB $HKPD $ARAY $ANGH $ABOS

1 · Reply

zoneclassman1 Feb. 20 at 5:15 PM

$SLS $IBRX $ABOS $CABA $ALT Your predictions are too good in this chart you shared about SELLAS. I joined your Biotech group very good stuff!

1 · Reply

jacksparo Feb. 20 at 2:19 PM

$SLS $IBRX $ABOS $CABA $ALT I will be watching, taking notes, and sharing my live updates as usual in my Live Biotech Group ( you want to join, the door is always open, email me, and again, not a free snack bar group)! It is an important day for the market! Options will expire today! I will be watching every single piece of the volume today!

1 · Reply

Acumen Pharmaceuticals, Inc. (ABOS) Q3 2025 Earnings Call Transcript

Sep 2, 2025, 9:28 PM EDT - 6 months ago

Acumen Pharmaceuticals, Inc. (ABOS) Presents At Citi's Biopharma Back To School Conference Transcript

Aug 26, 2025, 4:00 PM EDT - 6 months ago

Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences

Aug 12, 2025, 2:46 PM EDT - 7 months ago

Acumen Pharmaceuticals, Inc. (ABOS) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 7:00 AM EDT - 7 months ago

Acumen Pharmaceuticals Reports Second Quarter 2025 Financial Results and Business Highlights

Aug 5, 2025, 4:00 PM EDT - 7 months ago

Acumen Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 12, 2025

Jul 15, 2025, 7:00 AM EDT - 8 months ago

JCR Pharmaceuticals and Acumen Pharmaceuticals Announce Collaboration to Develop Therapy for Alzheimer's Disease, Enabled by J-Brain Cargo® Technology Platform

Jul 10, 2025, 8:00 AM EDT - 8 months ago

Acumen Pharmaceuticals to Present Studies on Cost Savings Associated with Use of pTau217 Screening Assay in Phase 2 ALTITUDE-AD Study and Sabirnetug Oligomer-Selectivity at the Alzheimer's Association International Conference (AAIC®) 2025

May 13, 2025, 10:11 AM EDT - 10 months ago

Acumen Pharmaceuticals, Inc. (ABOS) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:00 PM EDT - 10 months ago

Acumen Pharmaceuticals to Participate in the Bank of America Healthcare Conference

May 6, 2025, 4:00 PM EDT - 10 months ago

Acumen Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025

Apr 2, 2025, 7:00 AM EDT - 11 months ago

Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting

Mar 27, 2025, 10:05 AM EDT - 1 year ago

Acumen Pharmaceuticals, Inc. (ABOS) Q4 2024 Earnings Call Transcript

Mar 20, 2025, 4:00 PM EDT - 1 year ago

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

Mar 18, 2025, 8:48 AM EDT - 1 year ago

Acumen Pharmaceuticals CEO Discusses Novel Targeted Therapies for Alzheimer's

Mar 12, 2025, 8:00 AM EDT - 1 year ago

Acumen Pharmaceuticals to Present During International Conference on Alzheimer's and Parkinson's Diseases 2025 and American Academy of Neurology Annual Meeting

Nov 26, 2024, 4:00 PM EST - 1 year ago

Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Nov 12, 2024, 1:17 PM EST - 1 year ago

Acumen Pharmaceuticals, Inc. (ABOS) Q3 2024 Earnings Call Transcript

Nov 11, 2024, 4:00 PM EST - 1 year ago

Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference

Nov 6, 2024, 4:00 PM EST - 1 year ago

Acumen Pharmaceuticals to Participate in the UBS Global Healthcare Conference

Oct 31, 2024, 8:05 AM EDT - 1 year ago

Acumen Pharmaceuticals Presents Innovative Trial Screening Advancements Utilizing pTau217 Assay in Phase 2 Study of Sabirnetug for Early Alzheimer's Disease at the 17th Annual Clinical Trials on Alzheimer's Disease Conference

Oct 23, 2024, 8:00 AM EDT - 1 year ago

Acumen Pharmaceuticals to Deliver Late-Breaking Presentation at 17th Annual Clinical Trials on Alzheimer's Disease (CTAD) Conference

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Lucy Therapeutics Appoints Kim Drapkin as Board Chair

LENZ

Sep 30, 2024, 4:00 PM EDT - 1 year ago

Acumen Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference

Sep 25, 2024, 4:00 PM EDT - 1 year ago

Acumen Pharmaceuticals to Host Virtual R&D Day on Oct. 2, 2024

Sep 3, 2024, 4:00 PM EDT - 1 year ago

Acumen Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investor Conference

Aug 13, 2024, 11:17 AM EDT - 1 year ago

Acumen Pharmaceuticals, Inc. (ABOS) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 4:00 PM EDT - 1 year ago

Acumen Pharmaceuticals to Report Second Quarter Results on August 13, 2024

Jul 29, 2024, 8:38 PM EDT - 1 year ago

Acumen Pharmaceuticals: Healthy Cash Runway And Market Potential In Alzheimer's

Jul 29, 2024, 7:00 AM EDT - 1 year ago

Acumen Pharmaceuticals Announces First Subject Dosed in Phase 1 Study of Subcutaneous Sabirnetug (ACU193) for Early Alzheimer's Disease

Jul 28, 2024, 7:30 AM EDT - 1 year ago

Acumen Pharmaceuticals Presents Patient Experience and Biomarker Data from Phase 1 INTERCEPT-AD Study at the Alzheimer's Association International Conference (AAIC®) 2024

May 14, 2024, 12:46 PM EDT - 1 year ago

Acumen Pharmaceuticals, Inc. (ABOS) Q1 2024 Earnings Call Transcript

May 14, 2024, 7:00 AM EDT - 1 year ago

Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights

May 13, 2024, 4:00 PM EDT - 1 year ago

Acumen Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

May 8, 2024, 5:47 PM EDT - 1 year ago

Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference

May 8, 2024, 8:00 AM EDT - 1 year ago

Acumen Pharmaceuticals Announces First Patient Dosed in ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer's Disease

May 7, 2024, 4:00 PM EDT - 1 year ago

Acumen Pharmaceuticals to Report First Quarter Results on May 14, 2024

Apr 16, 2024, 8:00 AM EDT - 2 years ago

Acumen Pharmaceuticals Presents First Comprehensive Clinical and Biomarker Data for Sabirnetug (ACU193) at American Academy of Neurology 2024 Annual Meeting

Apr 4, 2024, 8:00 AM EDT - 2 years ago

Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer's Disease

Mar 26, 2024, 10:45 AM EDT - 2 years ago

Acumen Pharmaceuticals, Inc. (ABOS) Q4 2023 Earnings Call Transcript

Mar 26, 2024, 7:00 AM EDT - 2 years ago

Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2023 and Business Highlights

Mar 19, 2024, 4:00 PM EDT - 2 years ago

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2023 Financial Results on March 26, 2024

Mar 12, 2024, 4:00 PM EDT - 2 years ago

Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days

Mar 8, 2024, 8:50 AM EST - 2 years ago

Acumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer's at the AD/PD™ 2024 Annual Meeting

Feb 21, 2024, 8:00 AM EST - 2 years ago

Acumen Pharmaceuticals to Present Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer's at the AD/PD™ 2024 Annual Meeting

Feb 1, 2024, 7:00 AM EST - 2 years ago

Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer

Jan 4, 2024, 4:15 PM EST - 2 years ago

Acumen Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Nov 13, 2023, 4:29 PM EST - 2 years ago

Acumen Pharmaceuticals, Inc. (ABOS) Q3 2023 Earnings Call Transcript

Nov 13, 2023, 7:00 AM EST - 2 years ago

Acumen Pharmaceuticals Secures $50.0 Million Credit Facility with K2 HealthVentures

Nov 13, 2023, 7:00 AM EST - 2 years ago

Acumen Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Highlights

RoBERTTR87 Feb. 25 at 3:29 PM

$IBRX $SLS $ABOS $CABA $AKBA Best decision I joined your groups! I am learning a lot!

2 · Reply

jacksparo Feb. 25 at 1:09 PM

1 · Reply

Drerekcohert90 Feb. 24 at 10:15 PM

$SLS $IBRX $ABOS $CABA $ALT Jack I will spam the board for you lol! I am serious you did very well in IBRX but we need a bigger win in SLS!

12 · Reply

jacksparo Feb. 24 at 7:15 PM

$SLS $IBRX $ABOS $CABA $ALT Strong day across some Biotech spots!

0 · Reply

jacksparo Feb. 24 at 3:27 AM

1 · Reply

Geraldgenofranco1953 Feb. 23 at 2:26 PM

$SLS $ALT $ABOS $GUTS Let us go Jack!

0 · Reply

jacksparo Feb. 23 at 1:26 PM

$SLS $ALT $ABOS $GUTS I will be watching and sharing my live updates in my Telegram Biotech group let us see what this week will bring!

1 · Reply

topstockalerts Feb. 20 at 9:30 PM

After Hours Top Gainers $VHUB $HKPD $ARAY $ANGH $ABOS

1 · Reply

zoneclassman1 Feb. 20 at 5:15 PM

$SLS $IBRX $ABOS $CABA $ALT Your predictions are too good in this chart you shared about SELLAS. I joined your Biotech group very good stuff!

1 · Reply

jacksparo Feb. 20 at 2:19 PM

1 · Reply

matuli Feb. 20 at 7:37 AM

$ABOS go go go! 📈🚀

0 · Reply

SCEDIT Feb. 20 at 4:20 AM

$ABOS https://everyticker.com/quote/ABOS/analysis/acumen-pharmaceuticals-targeting-the-core-toxin-in-alzheimer-s-with-sabirnetug-nasdaq-abos

0 · Reply

johnwestt2025 Feb. 20 at 1:35 AM

$SLS $IBRX $ABOS $CABA $ALT Great chart! let us burn the shorts tomorrow! I am lucky to be in your group!

0 · Reply

jacksparo Feb. 19 at 11:37 PM

$SLS $IBRX $ABOS $CABA $ALT Green close is a good thing even if it’s slight green but the daily action with the volatility we saw was impressive. So far all as predicted in my end ✅! I am sharing real time chart info I draw my self and add all the levels plus the indicators I use ( full transparency) Some of my shared predictions in my Live Telegram groups are coming very accurate! More to come 📈📈🇺🇸🇺🇸📈📈!

1 · Reply

johnwestt2025 Feb. 19 at 4:14 PM

$IBRX $SLS $ABOS $OCGN $MIST I am in with you!

0 · Reply

Johnkerby1988 Feb. 19 at 2:10 PM

$IBRX $SLS $ABOS $OCGN $MIST I am locked and loaded already joined all your groups! worth every penny!

0 · Reply

jacksparo Feb. 19 at 1:13 PM

$IBRX $SLS $ABOS $OCGN $MIST Lets us see what today will bring! I will be taking all the possible notes for my incoming updates ( I share my live updates plus my trading plans only in my Biotech Telegram live group) . Some pressure in the market is also expected between today and tomorrow!

0 · Reply

Stockley_Bulbousberries Feb. 18 at 6:58 PM

$ABOS

0 · Reply

jacksparo Feb. 17 at 11:34 PM

$IBRX $SLS $ABOS $CABA Steady day overall but most likely Thursday/Friday action ( the 20th February expiration day for options) will be where the big fight this week! I am still sharing my live updates on daily/ hourly base with my trading plans in my Biotech Telegram live group!

0 · Reply

jacksparo Feb. 17 at 1:41 PM

$SLS $IBRX $ACRV $ABOS I will be watching and taking my notes all day long about some important biotech stocks . All my live updates will be shared in my Special Biotech Live group! Let us see what today will bring in!

0 · Reply

OfficialStocktwitsUser Feb. 16 at 4:42 PM

$ABOS RSI: 61.26, MACD: 0.1199 Vol: 0.32, MA20: 2.36, MA50: 2.14 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Adamchristlover Feb. 16 at 1:31 PM

$SLS $IBRX $IMUX $CABA $ABOS

0 · Reply

Market Cap	167.18M
Revenue (ttm)	0.00
Net Income (ttm)	-102.33M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.33

Volume	201,200
Avg Vol	678,464
Day's Range	N/A - N/A
Shares Out	60.57M
Stochastic %K	94%
Beta	0.24
Analysts	Strong Sell
Price Target	$7.25